Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. DSX
2. GNK
3. INTC
4. SPCX
5. III
6. TTEC
7. DAL
8. AWK
9. GZDIF
10. ATNI

Go back to Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update

Galectin Therapeutics (GALT) Reports Q2 Loss of $0.14/Share

August 14, 2017 8:21 AM EDT

Galectin Therapeutics (NASDAQ: GALT) reported Q2 EPS of ($0.14), versus ($0.20) reported last year.

For earnings history and earnings-related data on Galectin Therapeutics (GALT) click here.

... More